A Phase 3 interventional study of 5-fluorouracil Injection and Triamcinolone Acetonide in Chalazion, sponsored by University of Washington. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-02-06.
Sponsored by University of Washington · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies testing Triamcinolone Acetonide in Pain — 4 open to participants now, 4 under way, 2 of them phase 3. Triamcinolone Acetonide · Pain.
Among the 17 studies testing Triamcinolone Acetonide in Pain, this one is the 7th largest by planned enrollment, is the only one that started in 2013, is one of 6 in phase 3, and was the 2nd registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →4 of the 17 studies testing Triamcinolone Acetonide in Pain are open now, in 3 countries. Recruiting first, the newest first:
Tanta University · Sites in Egypt
Ages 40–75
Harrow Inc · Sites in United States
Ages 18+
Allama Iqbal Medical College · Sites in Pakistan
Ages 18–40 · Healthy volunteers
By country, each count listing its studies:
Triamcinolone Acetonide: first FDA approval 1958 (TRIAMCINOLONE ACETONIDE). What it is approved for, and how studies give it, is on its page →
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 1 started in 2013.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 120 is above the median of 66 across 8,512 interventional studies indexed under Pain.
Median enrollment 81 across the 17 interventional studies. Of the 13 that completed or were terminated, 12 (92%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 17 have an industry lead sponsor. The 6 most frequent:
University of Washington is the lead sponsor of 1,435 studies on the registry; 225 are open to participants now.
Of its 158 completed or terminated interventional studies of FDA-regulated products, 137 (87%) have results posted.
34 studies in Pain by University of Washington: 1 open now, 1 under way, 1 of them phase 3. Of 28 finished, 7 (25%) have results posted.
Among the 34 studies in Pain by University of Washington, this one is the 11th largest by planned enrollment of the 27 interventional ones that give a count, is one of 3 that started in 2013, is the only one in phase 3, and was the 21st registered.
University of Washington’s Pain studies by the year they started, since 2002.
1 of the studies testing Triamcinolone Acetonide in Pain that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07832552Phase 3Harrow IncA Phase 3 Study Evaluating the Safety and Efficacy of TRIESENCE® (Injectable Suspension) for the Treatment of Ocular Inflammation and Pain After Ophthalmic Surgery | 2026-12 |
Add it to your calendar (.ics) → With an account.
Among the 17 studies testing Triamcinolone Acetonide in Pain, from their registry updates:
Nothing recorded among them since 2026-09-25.
Among University of Washington’s 34 in Pain:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Local injection of 5-fluorouracil into a chalazion (stye) is as effective as local injection of triamcinolone (steroid) and incision and curettage for treatment of chalazia.
This is a prospective randomized interventional study comparing four current standard-of-care treatments for chalazia: incision and curettage, local injection of triamcinolone, local injection of 5-FU, and local injection of combination triamcinolone/5-FU.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
A vertical incision over the area of chalazion will be done. Inflammatory material will be removed and the chalazion capsule will be excised.
Procedure: Incision and Curettage
0.1 ml of triamcinolone is injected directly in the chalazion.
Drug: Triamcinolone Acetonide · Procedure: Incision and Curettage
0.1 ml of 5-fluorouracil is injected directly in the lesion transconjunctivally.
Drug: 5-fluorouracil Injection · Procedure: Incision and Curettage
0.1 ml of a 4:1 mixture of 4 parts 5-FU and 1 part triamcinolone is injected in the lesion.
Procedure: Incision and Curettage · Drug: Triamcinolone Acetonide/5-fluorouracil mixture
If the chalazion is present at follow-up visit, another injection of 5-FU will be given.
Also known as: 5-FU
If chalazion present at follow-up, another Triamcinolone injection will be done.
Also known as: triamcinolone
If chalazion present at follow-up visit, patient will be randomized to receive local injection of either triamcinolone, 5-FU, or triamcinolone/5-FU mixture.
If chalazion persists at follow-up visit, another injection of triamcinolone/5-FU mixture will be done.
Size of chalazion
Time frame: 4 weeks
The record gives a start of Dec 2013, a primary completion of Jul 2025 and a completion of Jul 2026. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Fluorouracil · Triamcinolone Acetonide